Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind?

被引:9
作者
Aletaha, D [1 ]
机构
[1] NIAMSD, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1186/ar1870
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Several pooled indices for the assessment of rheumatoid arthritis disease activity are available to rheumatologists. Face and criterion validity of these instruments can be assessed by determining the association of their measurements with opinions of physicians. Several confounding aspects must be considered in such analyses, especially blinding of the person( s) making the decisions to the instruments being studied and to the objective of the study in general. From several studies in the literature, there is currently no evidence that any one of the available composite indices is better or worse than any other. The choice of index in clinical practice should ideally be based on practical considerations related to the needs of the rheumatologist in the respective health care setting.
引用
收藏
页数:3
相关论文
共 9 条
[1]
Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states [J].
Aletaha, D ;
Ward, MM ;
Machold, KP ;
Nell, VPK ;
Stamm, T ;
Smolen, JS .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2625-2636
[2]
ALETAHA D, 2005, IN PRESS RHEUM DIS C
[3]
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment [J].
Cruyssen, BV ;
Van Looy, S ;
Wyns, B ;
Westhovens, R ;
Durez, P ;
Malaise, M ;
Verbruggen, L ;
Vastesaeger, N ;
Geldhof, A ;
Boullart, L ;
De Keyser, F .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (05) :R1063-R1071
[4]
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study [J].
Durez, P ;
Van den Bosch, F ;
Corluy, L ;
Veys, EM ;
De Clerck, L ;
Peretz, A ;
Malaise, M ;
Devogelaer, JP ;
Vastesaeger, N ;
Geldhof, A ;
Westhovens, R .
RHEUMATOLOGY, 2005, 44 (04) :465-468
[5]
Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? [J].
Mäkinen, H ;
Kautiainen, H ;
Hannonen, P ;
Sokka, T .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1410-1413
[6]
MODIFIED DISEASE-ACTIVITY SCORES THAT INCLUDE 28-JOINT COUNTS - DEVELOPMENT AND VALIDATION IN A PROSPECTIVE LONGITUDINAL-STUDY OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
PREVOO, MLL ;
VANTHOF, MA ;
KUPER, HH ;
VANLEEUWEN, MA ;
VANDEPUTTE, LBA ;
VANRIEL, PLCM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (01) :44-48
[7]
Soubrier M, 2004, ARTHRITIS RHEUM, V50, pS386
[8]
DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis [J].
van Riel, PLCM ;
Fransen, J .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (05) :189-190
[9]
JUDGING DISEASE-ACTIVITY IN CLINICAL-PRACTICE IN RHEUMATOID-ARTHRITIS - 1ST STEP IN THE DEVELOPMENT OF A DISEASE-ACTIVITY SCORE [J].
VANDERHEIJDE, DMFM ;
VANTHOF, MA ;
VANRIEL, PLCM ;
THEUNISSE, LAM ;
LUBBERTS, EW ;
VANLEEUWEN, MA ;
VANRIJSWIJK, MH ;
VANDEPUTTE, LBA .
ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (11) :916-920